Vir Biotechnology Inc banner

Intrinsic Value

Is VIR undervalued or overvalued?

See the intrinsic value estimate for Vir Biotechnology Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

VIR Intrinsic Value
LOCKED
Unlock
Today vs. history

VIR looks overvalued.
But is it expensive by its own standards?

See how today’s valuation compares with VIR’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor VIR
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price $10.52
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to VIR

Fundamental Analysis

What Vir Biotechnology Does

Biotechnology Health Care

Vir Biotechnology is a drug developer focused on infectious diseases. It works on antibody-based medicines and other immune-driven treatments that are designed to help the body fight viral infections, especially diseases where standard antiviral drugs are limited or not enough.

Headquarters
United States of America US
Employees
367
IPO date
Oct 11, 2019
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Vir Biotechnology Inc

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Ownership

VIR Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one VIR stock?

The intrinsic value for Vir Biotechnology Inc (VIR) under the Base Case is hidden USD.

Is VIR stock undervalued or overvalued?

Compared with the current market price of 10.52 USD, the stock appears hidden.

Back to Top